论文部分内容阅读
用MA方案对30例难治性急性非淋巴细胞白血病患者进行治疗 ,认为常规剂量MA方案治疗难治性及复发性ANLL疗效显著、副反应轻 ,使用较安全
30 patients with refractory acute non-lymphocytic leukemia were treated with MA regimen. It is considered that routine dose MA regimens are effective and safe for the treatment of refractory and relapsed ANLL, and they are safer to use.